Breast-cancer stromal cells with TP53 mutations [6]

New England Journal of Medicine

Volumn 358, Issue 15, 2008, Pages 1635-1636

  Zalcman, Gérard ^a   Bergot, Emmanuel ^a   Hainaut, Pierre ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

BREAST CANCER; BREAST EPITHELIUM; FAMILIAL CANCER; GENE MUTATION; GENETIC DATABASE; HUMAN; LETTER; LYMPH NODE METASTASIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; STROMA; BREAST TUMOR; GENETICS; MUTATION; NOTE; NUCLEOTIDE SEQUENCE; STROMA CELL; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; GENES, P53; HUMANS; MUTATION; STROMAL CELLS;

EID: 42049121114     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Soussi T, Asselain B, Hamroun D, et al. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 2006;12:62-9.
2. International Agency for Research on Cancer. IARC TP53 mutation database. (Accessed March 21, 2008, at http://www-p53.iarc.fr/MutantDetail.asp?TypeGraph= MutantValidation&Mutant=P89S.)
3. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002;19:607-14.
4. Kato S, Han SY, Liu W, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A 2003;100:8424-9.